|
|
| Line 1: |
Line 1: |
| | + | |
| | ==The Structure of SpoIISA and SpoIISB, a Toxin - Antitoxin System== | | ==The Structure of SpoIISA and SpoIISB, a Toxin - Antitoxin System== |
| | <StructureSection load='3o6q' size='340' side='right' caption='[[3o6q]], [[Resolution|resolution]] 2.50Å' scene=''> | | <StructureSection load='3o6q' size='340' side='right' caption='[[3o6q]], [[Resolution|resolution]] 2.50Å' scene=''> |
| | == Structural highlights == | | == Structural highlights == |
| - | <table><tr><td colspan='2'>[[3o6q]] is a 4 chain structure with sequence from [http://en.wikipedia.org/wiki/Bacillus_subtilis Bacillus subtilis]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3O6Q OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3O6Q FirstGlance]. <br> | + | <table><tr><td colspan='2'>[[3o6q]] is a 4 chain structure with sequence from [http://en.wikipedia.org/wiki/"bacillus_globigii"_migula_1900 "bacillus globigii" migula 1900]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3O6Q OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3O6Q FirstGlance]. <br> |
| | </td></tr><tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=MSE:SELENOMETHIONINE'>MSE</scene></td></tr> | | </td></tr><tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=MSE:SELENOMETHIONINE'>MSE</scene></td></tr> |
| - | <tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">BSU12830, spoIISA, ykaC ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=1423 Bacillus subtilis]), BSU12820, spoIISB ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=1423 Bacillus subtilis])</td></tr> | + | <tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">BSU12830, spoIISA, ykaC ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=1423 "Bacillus globigii" Migula 1900]), BSU12820, spoIISB ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=1423 "Bacillus globigii" Migula 1900])</td></tr> |
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3o6q FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3o6q OCA], [http://www.rcsb.org/pdb/explore.do?structureId=3o6q RCSB], [http://www.ebi.ac.uk/pdbsum/3o6q PDBsum]</span></td></tr> | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3o6q FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3o6q OCA], [http://pdbe.org/3o6q PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=3o6q RCSB], [http://www.ebi.ac.uk/pdbsum/3o6q PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=3o6q ProSAT]</span></td></tr> |
| | </table> | | </table> |
| | == Function == | | == Function == |
| Line 17: |
Line 18: |
| | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> |
| | </div> | | </div> |
| | + | <div class="pdbe-citations 3o6q" style="background-color:#fffaf0;"></div> |
| | == References == | | == References == |
| | <references/> | | <references/> |
| | __TOC__ | | __TOC__ |
| | </StructureSection> | | </StructureSection> |
| - | [[Category: Bacillus subtilis]] | + | [[Category: Bacillus globigii migula 1900]] |
| | [[Category: Barak, I]] | | [[Category: Barak, I]] |
| | [[Category: Blagova, E V]] | | [[Category: Blagova, E V]] |
| Structural highlights
Function
[SP2SA_BACSU] Toxic component of a toxin-antitoxin (TA) module. Its toxic activity is neutralized by cognate antitoxin SpoIISB. Expression in the absence of SpoIISB permits sporulation to stage II, when plasmolysis zones and holes in the peptidoglycan layer are observed, resulting in cell death. Lethal when synthesized during vegetative growth in the absence of SpoIISB. In E.coli both the membrane bound and soluble domain are required in cis for toxin activity.[1] [SP2SB_BACSU] Antitoxin component of a toxin-antitoxin (TA) module. Antitoxin that binds cognate toxin SpoIISA and neutralizes its toxic activity; unlike most antitoxins it does not seem to be highly labile upon expression in E.coli.[2]
Publication Abstract from PubMed
Spore formation in Bacillus subtilis begins with an asymmetric cell division following which differential gene expression is established by alternative compartment-specific RNA polymerase sigma factors. The spoIISAB operon of B. subtilis was identified as a locus whose mutation leads to increased activity of the first sporulation-specific sigma factor, SigF. Inappropriate spoIISA expression causes lysis of vegetatively growing B. subtilis cells and E. coli cells when expressed heterologously, effects that are countered by co-expression of spoIISB, identifying SpoIISA-SpoIISB as a toxin-antitoxin system. SpoIISA has three putative membrane-spanning segments and a cytoplasmic domain. Here, the crystal structure of a cytoplasmic fragment of SpoIISA (CSpoIISA) in complex with SpoIISB has been determined by SeMet-MAD phasing to 2.5 A spacing revealing a CSpoIISA2: SpoIISB2 heterotetramer. CSpoIISA has a single domain alpha-beta structure resembling a GAF domain with an extended alpha-helix at its amino terminus. The two CSpoIISA protomers form extensive interactions through an intermolecular 4-helix bundle. Each SpoIISB chain is highly extended and lacking tertiary structure. The SpoIISB chains wrap around the CSpoIISA dimer forming extensive interactions with both CSpoIISA protomers. CD spectroscopy experiments indicate that SpoIISB is a natively disordered protein that adopts structure only in the presence of CSpoIISA while surface plasmon resonance experiments revealed that the CSpoIISA: SpoIISB complex is stable with a dissociation constant in the nanomolar range. The results are interpreted in relation to sequence conservation and mutational data and possible mechanisms of cell killing by SpoIISA are discussed.
The structure and interactions of SpoIISA and SpoIISB, a toxin-antitoxin system in Bacillus subtilis.,Florek P, Levdikov VM, Blagova E, Lebedev AA, Skrabana R, Resetarova S, Pavelcikova P, Barak I, Wilkinson AJ J Biol Chem. 2010 Dec 7. PMID:21147767[3]
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
References
- ↑ Adler E, Barak I, Stragier P. Bacillus subtilis locus encoding a killer protein and its antidote. J Bacteriol. 2001 Jun;183(12):3574-81. PMID:11371520 doi:10.1128/JB.183.12.3574-3581.2001
- ↑ Adler E, Barak I, Stragier P. Bacillus subtilis locus encoding a killer protein and its antidote. J Bacteriol. 2001 Jun;183(12):3574-81. PMID:11371520 doi:10.1128/JB.183.12.3574-3581.2001
- ↑ Florek P, Levdikov VM, Blagova E, Lebedev AA, Skrabana R, Resetarova S, Pavelcikova P, Barak I, Wilkinson AJ. The structure and interactions of SpoIISA and SpoIISB, a toxin-antitoxin system in Bacillus subtilis. J Biol Chem. 2010 Dec 7. PMID:21147767 doi:10.1074/jbc.M110.172429
|
